​
​

Entero Therapeutics Ownership | Who Owns Entero Therapeutics?

OverviewForecastRevenueFinancialsChart

Entero Therapeutics Ownership Summary

Entero Therapeutics is owned by 1.11% institutional investors, and 98.89% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.36% of its assets in Entero Therapeutics shares.

FWBI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEntero Therapeutics1.11%-98.89%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202215-533,210-2.51%185.63%7-2-
Mar 31, 202215-6.25%546,962-23.58%151.30%7-12.50%2-50.00%
Dec 31, 20211614.29%715,71033.20%1119.09%8-42.86%4-
Sep 30, 202114-537,339-1-14---

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index10.04K0.36%-91.00
Vanguard Institutional Extnd Mkt Idx Tr4.54K0.16%-
Fidelity Series Total Market Index717.000.03%-
Spartan Extended Market Index Pool E91.000.00%91.00
SSgA U.S. Extended Market Index Class I5.000.00%-1.00
State St US Extended Mkt Indx NL Cl C5.000.00%-
NT Ext Equity Mkt Idx Fd - NL1.00--
NT Ext Equity Mkt Idx Fd - DC - NL - T21.00--
SSgA U.S. Total Market Index Strategy1.00--
NT Ext Equity Mkt Idx Fd - L1.00--1.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 01, 2024SAPIRSTEIN JAMES Chairman and CEOSell$735.92
Apr 01, 2024Romano Sarah Chief Financial OfficerSell$317.21
Mar 15, 2024SAPIRSTEIN JAMES Chairman and CEOSell$9.36K
Mar 15, 2024Romano Sarah Chief Financial OfficerSell$5.56K
Jan 12, 2024Romano Sarah Chief Financial OfficerSell$411.60

Insider Transactions Trends

DateBuySell
2024 Q2-2
2024 Q1-4
2023 Q4-2
2023 Q3-4
2023 Q2-2

FWBI Ownership FAQ

Who Owns Entero Therapeutics?

Entero Therapeutics shareholders are primarily institutional investors at 1.11%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Entero Therapeutics's industry, Biotech Stocks , is 44.97%, which Entero Therapeutics falls below.

Does Blackrock own Entero Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Entero Therapeutics.

Who is the top mutual fund holder of Entero Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Entero Therapeutics shares, with 0.36% of its total shares outstanding invested in 10.04K Entero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools